Tranexamic acid use in sarcoma surgery patients: A systematic review and meta-analysis.

Victoria Giglio Aaron Michael GazendamHadia FarrukhAnthony GriffinPeter FergusonJay WunderKim Tsoi

Published in: Journal of surgical oncology (2024)

Despite evidence of reduced blood loss, the absence of prospective studies limits conclusive recommendations on TXA use in sarcoma surgery. Further research is warranted to determine optimal TXA regimens and assess safety concerns regarding thrombotic events in this patient population.

Keyphrases

minimally invasive
coronary artery bypass
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
surgical site infection
peritoneal dialysis
clinical practice
patient reported outcomes
atrial fibrillation